Free Trial
NASDAQ:AFIB

Acutus Medical (AFIB) Stock Price, News & Analysis

Acutus Medical logo

About Acutus Medical Stock (NASDAQ:AFIB)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
31 shs
Average Volume
6,655 shs
Market Capitalization
$3 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Acutus Medical, Inc. was a medical device company focused on improving the diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation. The company developed technologies intended to help electrophysiologists create detailed three-dimensional maps of the heart and guide catheter-based ablation procedures.

Its principal product was the AcQMap electrophysiology imaging and mapping system, which combined ultrasound-based imaging with electrical mapping to visualize cardiac anatomy and arrhythmia activity. The system was designed to support the identification of abnormal electrical signals and assist physicians in planning and performing ablation treatments. Acutus also developed associated mapping catheters, software and related procedural tools.

Founded in 2011 and headquartered in Carlsbad, California, Acutus marketed its products in the United States and select international markets, including Europe. The company completed its initial public offering on the Nasdaq under the symbol AFIB in 2020. In 2023, Acutus announced an agreement to sell substantially all of its assets to Medtronic, after which its standalone operations were wound down.

AI Generated. May Contain Errors.

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AFIB Stock News Headlines

AFIB Acutus Medical, Inc. - Seeking Alpha
Elon's next millionaires start October 24?
SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into millionaires. One welder's $10,000 stock package made him a millionaire on IPO day. Former Wall Street CEO Dylan Jovine says Elon Musk's next venture could outsize everything he's built before. It runs on an obscure AI firm Musk has relied on since 2012, supplying crucial technology to Tesla, Starlink and SpaceX.tc pixel
Acutus Medical Reports Full Year 2024 Financial Results
Acutus Medical Announces Operational Downsizing
Acutus Medical Reports Q3 2024 Financial Results
See More Headlines

AFIB Stock Analysis - Frequently Asked Questions

Acutus Medical, Inc. (NASDAQ:AFIB) issued its quarterly earnings data on Thursday, November, 11th. The company reported ($0.94) EPS for the quarter, missing the consensus estimate of ($0.92) by $0.02. The company earned $4.60 million during the quarter, compared to analysts' expectations of $6.02 million. Acutus Medical had a negative trailing twelve-month return on equity of 311.64% and a negative net margin of 272.74%.

Acutus Medical subsidiaries include Acutus Medical N.V..

Acutus Medical (AFIB) raised $126 million in an IPO on Thursday, August 6th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Walt Disney (DIS), Moderna (MRNA), NVIDIA (NVDA), Shopify (SHOP), AMC Entertainment (AMC), Alibaba Group (BABA) and Salesforce (CRM).

Company Calendar

Last Earnings
11/11/2021
Today
10/15/2026
Next Earnings (Estimated)
11/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:AFIB
CIK
1522860
Employees
85
Year Founded
2011

Profitability

EPS (Trailing Twelve Months)
($0.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.66 million
Net Margins
-272.74%
Pretax Margin
-30.32%
Return on Equity
-311.64%
Return on Assets
-11.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.85
Quick Ratio
1.57

Sales & Book Value

Annual Sales
$7.16 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
29,912,000
Free Float
28,228,000
Market Cap
$3 thousand
Optionable
No Data
Beta
5.71

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:AFIB) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners